‌

US Patent 10144750 Dioxolane analogues of cytidine for the treatment of cancer

Patent 10144750 was granted and assigned to Medivir on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Medivir

Current Assignee

Medivir

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101447500

Patent Inventor Names

Fredrik Oberg0

Richard Bethell0

Anders Eneroth0

Bjorn Klasson0

Date of Patent

December 4, 2018

Patent Application Number

155066920

Date Filed

August 24, 2015

Patent Citations Received

‌

US Patent 11447511 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10336780 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10456413 Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabine

‌

US Patent 10654877 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10822360 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10960017 Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancer

Patent Primary Examiner

‌

Deepak R Rao

Patent abstract

The invention provides compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10144750 Dioxolane analogues of cytidine for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API